Andrew Stewart Plump
President, R&D, Director · TAKEDA PHARMACEUTICAL CO LTD
- 2026
- Sep 4, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Stewart Plump files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Julie So-Young Kim - $1.52M in TAK purchases and sales in the last 12 months
- Lauren Rusckowski Duprey - $1.45M in TAK purchases and sales in the last 12 months
- Nicola Deidre Petal Greenway - $957K in TAK purchases and sales in the last 12 months
- Teresa Marie Bitetti - $855K in TAK purchases and sales in the last 12 months
- Giles Richard Platford - $532K in TAK purchases and sales in the last 12 months
- Natalie Anne Marie Furney - $528K in TAK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Stewart Plump?
Andrew Stewart Plump is a corporate insider, tracked as President, R&D, Director of TAKEDA PHARMACEUTICAL CO LTD (TAK). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew Stewart Plump submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Andrew Stewart Plump been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($5.34M) across all tracked filings.
